Indication
Prevention of nerve agent poisoning
The prevention of nerve agent poisoning refers to medical pretreatment strategies deployed before potential exposure to organophosphorus chemical warfare agents—such as soman, sarin, tabun, or VX—to mitigate life-threatening toxicity. Read more about Prevention of nerve agent poisoning
20 drugs 17 manufacturers
Drugs that treat it
Common Prevention of nerve agent poisoning therapies.
MESTINON (pyridostigmine bromide)
PYRIDOSTIGMINE BROMIDE
PYRIDOSTIGMINE BROMIDE
PYRIDOSTIGMINE BROMIDE
MESTINON (pyridostigmine bromide)
MESTINON (pyridostigmine bromide)
PYRIDOSTIGMINE BROMIDE
PYRIDOSTIGMINE BROMIDE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonThe prevention of nerve agent poisoning refers to medical pretreatment strategies deployed before potential exposure to organophosphorus chemical warfare agents—such as soman, sarin, tabun, or VX—to mitigate life-threatening toxicity.
These agents irreversibly inhibit acetylcholinesterase throughout the central, peripheral, and autonomic nervous systems, provoking excessive acetylcholine accumulation at muscarinic and nicotinic receptors.
This hyperstimulation triggers a rapid, life-threatening cholinergic crisis marked by copious bronchorrhea, bronchospasm, neuromuscular weakness, fasciculations, seizures, and fatal respiratory failure.
Pretreatment typically targets individuals at imminent risk, such as military personnel or emergency response teams, aiming to protect a fraction of acetylcholinesterase enzymes from permanent covalent bonding and subsequent enzymatic "aging".
- nih.gov
The prevention of nerve agent poisoning refers to medical pretreatment strategies deployed before potential exposure to organophosphorus chemical warfare agents—such as soman, sarin, tabun, or VX—to mitigate life-threatening toxicity
- nih.gov
The prevention of nerve agent poisoning refers to medical pretreatment strategies deployed before potential exposure to organophosphorus chemical warfare agents—such as soman, sarin, tabun, or VX—to mitigate life-threatening toxicity
- nih.gov
These agents irreversibly inhibit acetylcholinesterase throughout the central, peripheral, and autonomic nervous systems, provoking excessive acetylcholine accumulation at muscarinic and nicotinic receptors This hyperstimulation triggers a rapid, life-threatening cholinergic crisis marked by copious bronchorrhea, bronchospasm, neuromuscular weakness, fasciculations, seizures, and fatal respiratory failure
- nih.gov
These agents irreversibly inhibit acetylcholinesterase throughout the central, peripheral, and autonomic nervous systems, provoking excessive acetylcholine accumulation at muscarinic and nicotinic receptors This hyperstimulation triggers a rapid, life-threatening cholinergic crisis marked by copious bronchorrhea, bronchospasm, neuromuscular weakness, fasciculations, seizures, and fatal respiratory failure Pretreatment typically targets individuals at imminent risk, such as military personnel or ...
- fda.gov
Pretreatment typically targets individuals at imminent risk, such as military personnel or emergency response teams, aiming to protect a fraction of acetylcholinesterase enzymes from permanent covalent bonding and subsequent enzymatic "aging"
- fda.gov
Pretreatment typically targets individuals at imminent risk, such as military personnel or emergency response teams, aiming to protect a fraction of acetylcholinesterase enzymes from permanent covalent bonding and subsequent enzymatic "aging"
Personalize your experience
Follow Prevention of nerve agent poisoning and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.